Latest news with #JeffreyBailly
Globe and Mail
4 days ago
- Business
- Globe and Mail
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Goldman Sachs 46th Annual Global Healthcare Conference
NEWBURYPORT, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), today announced that Jeffrey Bailly, Chairman and CEO, and Ron Lataille, Sr. Vice President & CFO, will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025. UFP's fireside chat is scheduled to begin at 11:20 AM ET. About UFP Technologies, Inc. UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsourcing partner to many of the top medical device manufacturers in the world. The Company's single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. Contact:
Yahoo
06-05-2025
- Business
- Yahoo
UFP Technologies (NASDAQ:UFPT) Reports Upbeat Q1, Stock Soars
Medical products company UFP Technologies (NASDAQ:UFPT) reported Q1 CY2025 results topping the market's revenue expectations , with sales up 41.1% year on year to $148.1 million. Its non-GAAP profit of $2.47 per share was 22.9% above analysts' consensus estimates. Is now the time to buy UFP Technologies? Find out in our full research report. UFP Technologies (UFPT) Q1 CY2025 Highlights: Revenue: $148.1 million vs analyst estimates of $139.9 million (41.1% year-on-year growth, 5.9% beat) Adjusted EPS: $2.47 vs analyst estimates of $2.01 (22.9% beat) Adjusted EBITDA: $30.24 million vs analyst estimates of $28.26 million (20.4% margin, 7% beat) Operating Margin: 15.6%, in line with the same quarter last year Market Capitalization: $1.52 billion 'I am very pleased with our first quarter results and continued progress on a number of key strategic fronts,' said R. Jeffrey Bailly, Chairman & CEO. Company Overview With expertise dating back to 1963 in specialized materials and precision manufacturing, UFP Technologies (NASDAQ:UFPT) designs and manufactures custom solutions for medical devices, sterile packaging, and other highly engineered products for healthcare and industrial applications. Sales Growth A company's long-term sales performance is one signal of its overall quality. Any business can have short-term success, but a top-tier one grows for years. Over the last five years, UFP Technologies grew its sales at an excellent 24.2% compounded annual growth rate. Its growth beat the average healthcare company and shows its offerings resonate with customers. UFP Technologies Quarterly Revenue Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. UFP Technologies's annualized revenue growth of 20% over the last two years is below its five-year trend, but we still think the results suggest healthy demand. UFP Technologies Year-On-Year Revenue Growth This quarter, UFP Technologies reported magnificent year-on-year revenue growth of 41.1%, and its $148.1 million of revenue beat Wall Street's estimates by 5.9%. Looking ahead, sell-side analysts expect revenue to grow 9.1% over the next 12 months, a deceleration versus the last two years. Still, this projection is admirable and implies the market is baking in success for its products and services. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) stock benefiting from the rise of AI. Click here to access our free report one of our favorites growth stories.
